Drug Discovery - Medicine.net

DeepMind Open-Sources AlphaFold 3: Transforming the Future of Biological Research and Drug Discovery

DeepMind, the AI-focused subsidiary of Google, has officially open-sourced AlphaFold 3, the latest version of its revolutionary protein structure prediction tool.

Updated on: November 23,2024

0

DeepMind Open-Sources AlphaFold 3: Transforming the Future of Biological Research and Drug Discovery

DeepMind, the AI-focused subsidiary of Google, has officially open-sourced AlphaFold 3, the latest version of its revolutionary protein structure prediction tool.

Updated on:November 23,2024

0

Researchers induce brain activation using infrared light-controlled drugs

by Institute for Bioengineering of Catalonia (IBEC)Credit: Unsplash/CC0 Public DomainStudying the brain remains one of the most challenging endeavors in neuroscience. Researchers have explored various

Updated on: January 05,2024

7

Researchers induce brain activation using infrared light-controlled drugs

by Institute for Bioengineering of Catalonia (IBEC)Credit: Unsplash/CC0 Public DomainStudying the brain remains one of the most challenging endeavors in neuroscience. Researchers have explored various

Updated on:January 05,2024

7

PNAS | AlphaFold2 combined with supercomputing accelerates biophysical discoveries

The authors deployed APACE on the Delta and Polaris supercomputers and quantified its performance in accurate protein structure prediction using four typical proteins (6AWO, 6OAN, 7MEZ, and 6D6U). Utilizing up to 300 combinations distributed across 200 NV

Updated on: September 21,2024

0

PNAS | AlphaFold2 combined with supercomputing accelerates biophysical discoveries

The authors deployed APACE on the Delta and Polaris supercomputers and quantified its performance in accurate protein structure prediction using four typical proteins (6AWO, 6OAN, 7MEZ, and 6D6U). Utilizing up to 300 combinations distributed across 200 NV

Updated on:September 21,2024

0

Can a twice-a-year shot help end the HIV/AIDS epidemic

Science journalist Jon Cohen, physician-scientist Linda-Gail Bekker, and biochemist Wesley Sundquist describe the history of HIV/AIDS prevention and the unique mechanism that led lenacapavir to be named the 2024 Breakthrough of the Year.

Updated on: December 24,2024

0

Can a twice-a-year shot help end the HIV/AIDS epidemic

Science journalist Jon Cohen, physician-scientist Linda-Gail Bekker, and biochemist Wesley Sundquist describe the history of HIV/AIDS prevention and the unique mechanism that led lenacapavir to be named the 2024 Breakthrough of the Year.

Updated on:December 24,2024

0

Weekly Update of Drug News-25/11/2024

Updated on: November 25,2024

0

Weekly Update of Drug News-25/11/2024

Updated on:November 25,2024

0

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.

Updated on: December 13,2024

0

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.

Updated on:December 13,2024

0

AI-Powered Breakthrough: Novo Nordisk and Valo Health Expand $4.6B Partnership to Revolutionize Cardiometabolic Disease Treatment

In a significant expansion of their technological partnership, pharmaceutical giant Novo Nordisk and AI-driven healthcare innovator Valo Health have broadened their collaborative efforts in medical research.

Updated on: January 09,2025

0

AI-Powered Breakthrough: Novo Nordisk and Valo Health Expand $4.6B Partnership to Revolutionize Cardiometabolic Disease Treatment

In a significant expansion of their technological partnership, pharmaceutical giant Novo Nordisk and AI-driven healthcare innovator Valo Health have broadened their collaborative efforts in medical research.

Updated on:January 09,2025

0